Correlation Between OWC Pharmaceutical and Supernus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OWC Pharmaceutical and Supernus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OWC Pharmaceutical and Supernus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OWC Pharmaceutical Research and Supernus Pharmaceuticals, you can compare the effects of market volatilities on OWC Pharmaceutical and Supernus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OWC Pharmaceutical with a short position of Supernus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of OWC Pharmaceutical and Supernus Pharmaceuticals.

Diversification Opportunities for OWC Pharmaceutical and Supernus Pharmaceuticals

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between OWC and Supernus is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding OWC Pharmaceutical Research and Supernus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supernus Pharmaceuticals and OWC Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OWC Pharmaceutical Research are associated (or correlated) with Supernus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supernus Pharmaceuticals has no effect on the direction of OWC Pharmaceutical i.e., OWC Pharmaceutical and Supernus Pharmaceuticals go up and down completely randomly.

Pair Corralation between OWC Pharmaceutical and Supernus Pharmaceuticals

Given the investment horizon of 90 days OWC Pharmaceutical Research is expected to generate 168.42 times more return on investment than Supernus Pharmaceuticals. However, OWC Pharmaceutical is 168.42 times more volatile than Supernus Pharmaceuticals. It trades about 0.4 of its potential returns per unit of risk. Supernus Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest  0.00  in OWC Pharmaceutical Research on August 26, 2024 and sell it today you would earn a total of  0.01  from holding OWC Pharmaceutical Research or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OWC Pharmaceutical Research  vs.  Supernus Pharmaceuticals

 Performance 
       Timeline  
OWC Pharmaceutical 

Risk-Adjusted Performance

25 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OWC Pharmaceutical Research are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental indicators, OWC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.
Supernus Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Supernus Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Supernus Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

OWC Pharmaceutical and Supernus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OWC Pharmaceutical and Supernus Pharmaceuticals

The main advantage of trading using opposite OWC Pharmaceutical and Supernus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OWC Pharmaceutical position performs unexpectedly, Supernus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will offset losses from the drop in Supernus Pharmaceuticals' long position.
The idea behind OWC Pharmaceutical Research and Supernus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
FinTech Suite
Use AI to screen and filter profitable investment opportunities